MedTrace Logo

Tailored Messaging for CRC Screening

NCT03310892 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2023-10-04

No results posted yet for this study

Summary

This is a randomized controlled trial to to determine whether direct, tailored messaging to patients prior to scheduling colonoscopy will increase patient adherence to provider recommendation for screening colonoscopy.

Conditions

Interventions

BEHAVIORAL

Generic message

Generic message

BEHAVIORAL

Tailored message

Tailored message

Sponsors & Collaborators

Principal Investigators

  • Michael L Kochman, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-09
Primary Completion
2023-06-30
Completion
2023-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03310892 on ClinicalTrials.gov